Gross Profit (TTM) Chart

View Gross Profit (TTM) for SERA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (TTM) Chart
Start Trial

Historical Gross Profit (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -0.86M
March 31, 2026 -0.91M
December 31, 2025 -0.907M
September 30, 2025 -0.86M
June 30, 2025 -0.806M
March 31, 2025 -0.918M
December 31, 2024 -0.942M
September 30, 2024 -0.937M
June 30, 2024 -1.102M
March 31, 2024 -1.046M
December 31, 2023 -1.16M
September 30, 2023 -1.287M
June 30, 2023 -1.108M
Date Value
March 31, 2023 -0.998M
December 31, 2022 -0.818M
September 30, 2022 -0.629M
June 30, 2022 -0.545M
March 31, 2022 -0.555M
December 31, 2021 -0.601M
September 30, 2021 -0.667M
June 30, 2021 -0.778M
March 31, 2021 -0.786M
December 31, 2020 -0.815M
September 30, 2020 -0.616M
June 30, 2020 -0.418M
March 31, 2020 -0.222M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Myriad Genetics, Inc. 525.10M
BioRestorative Therapies, Inc. 0.119M
CareDx, Inc. 321.18M
Natera, Inc. 1.753B
Exagen, Inc. 41.70M